Movement Disorders · 2019 · 30 citations · 23 references
Life SciencesNeurologyNeuroscienceClinical NeuroscienceDiagnostic ImagingNeurodegenerationBiomarkers Of NeurodegenerationBrain ImagingNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinsonian DisordersBiomarkers Of Parkinsonian DisordersClinical Diagnosis Of ParkinsonismImaging Biomarker ValidationMetabolic Network AnalysisMovement Disorder BiomarkersNeuroimaging In Parkinson's DiseaseParkinson Disease BiomarkersParkinson Disease Imaging
BACKGROUND: An ideal imaging biomarker for a neurodegenerative disorder should be able to measure abnormalities in the earliest stages of the disease. OBJECTIVE: We investigated metabolic network changes in two independent cohorts of drug-naïve Parkinson's disease (PD) patients who have not been exposed to dopaminergic medication. METHODS: F]-fluorodeoxyglucose PET. All patients had clinical follow-ups to verify the diagnosis of idiopathic PD. Spatial covariance analysis was used to identify and validate de novo PD-related metabolic patterns in the Italian and U.S. cohorts. We compared the de novo PD-related metabolic patterns to the original PD-related pattern that was identified in more advanced patients who had been on chronic dopaminergic treatment. RESULTS: De novo PD-related metabolic patterns were identified in each of the two independent cohorts of drug-naïve PD patients, and each differentiated PD patients from healthy control subjects. Expression values for these disease patterns were elevated in drug-naïve PD patients relative to healthy controls in the identification as well as in each of the validation subgroups. The two de novo PD-related metabolic patterns were topographically very similar to each other and to the original PD-related pattern. CONCLUSIONS: Reproducible PD-related patterns are expressed in de novo, drug-naïve PD patients. In PD, disease-related metabolic patterns have stereotyped topographies that develop independently of chronic levodopa treatment. © 2019 International Parkinson and Movement Disorder Society.
23
Changes in network activity with the progression of Parkinson's disease
Chaorui Huang, Chengke Tang, Andrew Feigin et al. · Brain · 2007 · 398 citations · Full text
Network structure of brain atrophy in de novo Parkinson's disease
Yashar Zeighami, Miguel Ulla, Yasser Iturria‐Medina et al. · eLife · 2015 · 259 citations · Full text
Medicine, Neurology, Neuroscience +17